Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis
- 1 July 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 19 (7), 1550-1561
- https://doi.org/10.1158/1535-7163.MCT-19-0910
Abstract
Glioma is one of the most common primary malignant tumors of the central nervous system accounting for approximately 40% of all intracranial tumors. Temozolomide is a conventional chemotherapy drug for adjuvant treatment of patients with high-risk gliomas, including grade II to grade IV. Our bioinformatic analysis of The Cancer Genome Atlas and Chinese Glioma Genome Atlas datasets and immunoblotting assay show that SLC12A2 gene and its encoded Na+-K+-2Cl(-) cotransporter isoform 1 (NKCC1) protein are abundantly expressed in grade II-IV gliomas. NKCC1 regulates cell volume and intracellular Cl- concentration, which promotes glioma cell migration, resistance to temozolomide, and tumor-related epilepsy in experimental glioma models. Using mouse syngeneic glioma models with intracranial transplantation of two different glioma cell lines (GL26 and SB28), we show that NKCC1 protein in glioma tumor cells as well as in tumor-associated reactive astrocytes was significantly upregulated in response to temozolomide monotherapy. Combination therapy of temozolomide with the potent NKCC1 inhibitor bumetanide reduced tumor proliferation, potentiated the cytotoxic effects of temozolomide, decreased tumor-associated reactive astrogliosis, and restored astrocytic GLT-1 and GLAST glutamate transporter expression. The combinatorial therapy also led to suppressed tumor growth and prolonged survival of mice bearing GL26 glioma cells. Taken together, these results demonstrate that NKCC1 protein plays multifaceted roles in the pathogenesis of glioma tumors and presents as a therapeutic target for reducing temozolomide-mediated resistance and tumor-associated astrogliosis.Other Versions
Funding Information
- China Scholarship Council
- Pitt | Medical Center, University of Pittsburgh
- Pitt | Department of Neurology, University of Pittsburgh
This publication has 42 references indexed in Scilit:
- Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative GroupNeuro-Oncology, 2012
- Regulation of Brain Tumor Dispersal by NKCC1 Through a Novel Role in Focal Adhesion RegulationPLoS Biology, 2012
- Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma MicroenvironmentPLOS ONE, 2012
- Inhibition of Na+-K+-2ClCotransporter isoform 1 Accelerates Temozolomidemediated Apoptosis in Glioblastoma Cancer CellsCellular Physiology and Biochemistry, 2012
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Ion channels and tranporters in cancer. 2. Ion channels and the control of cancer cell migrationAmerican Journal of Physiology-Cell Physiology, 2011
- Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 Reduces Glioma InvasionCancer Research, 2010
- Chloride Ion Modulates Cell Proliferation of Human Androgen-independent Prostatic Cancer CellCellular Physiology and Biochemistry, 2010
- Furosemide, a Blocker of Na+/K+/2Cl− Cotransporter, Diminishes Proliferation of Poorly Differentiated Human Gastric Cancer Cells by Affecting G0/G1 StateThe Journal of Physiological Sciences, 2006
- Proliferating cell nuclear antigen expression in central nervous system neoplasmsVirchows Archiv A Pathological Anatomy and Histopathology, 1991